Buflomedil
From Self-sufficiency
| Buflomedil | |
|---|---|
| File:Buflomedil.svg | |
| 4-(pyrrolidin-1-yl)-1-(2,4,6-trimethoxyphenyl)butan-1-one | |
| style="background: #F8EABA; text-align: center;" colspan="2" | Identifiers | |
| CAS number | 55837-25-7 |
| PubChem | 2467 |
| SMILES | Script error: No such module "collapsible list". |
| style="background: #F8EABA; text-align: center;" colspan="2" | Properties | |
| Molecular formula | C17H25NO4 |
| Molar mass | 307.38 g/mol |
| Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) | |
| Infobox references | |
Buflomedil is a vasoactive drug used to treat claudication or the symptoms of peripheral arterial disease. It is currently not approved by the FDA for use in the United States.
References
 | This article does not cite any references or sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (April 2008) |
Cite error: Invalid <references> tag;
parameter "group" is allowed only.
<references />, or <references group="..." />
| 30px | This drug article relating to the cardiovascular system is a stub. You can help ssf by expanding it. |
